Qfitlia (fitusiran) is a first-in-class AT-lowering therapy approved by the NMPA. Qfitlia prevents bleeds and helps rebalance hemostasis by lowering AT, a protein that inhibits blood clotting, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback